These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 12911856)

  • 1. Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus.
    Piriou L; Chevallier S; Hutet E; Charley B; Le Potier MF; Albina E
    Vet Res; 2003; 34(4):389-404. PubMed ID: 12911856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo.
    Rau H; Revets H; Balmelli C; McCullough KC; Summerfield A
    Vet Res; 2006; 37(1):155-68. PubMed ID: 16336932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of cytokine production and CD25 expression by porcine lymphocyte subpopulations following exposure to classical swine fever virus (CSFV).
    Suradhat S; Sada W; Buranapraditkun S; Damrongwatanapokin S
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):197-208. PubMed ID: 15963818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
    Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
    Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
    Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
    Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV.
    Tarradas J; Álvarez B; Fraile L; Rosell R; Muñoz M; Galindo-Cardiel I; Domingo M; Dominguez J; Ezquerra A; Sobrino F; Ganges L
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):243-51. PubMed ID: 21684019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of virus-specific peripheral blood cell cytokine responses following vaccination or infection with classical swine fever viruses.
    Graham SP; Everett HE; Johns HL; Haines FJ; La Rocca SA; Khatri M; Wright IK; Drew T; Crooke HR
    Vet Microbiol; 2010 Apr; 142(1-2):34-40. PubMed ID: 19854006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
    Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
    Tarradas J; Monsó M; Muñoz M; Rosell R; Fraile L; Frías MT; Domingo M; Andreu D; Sobrino F; Ganges L
    Vaccine; 2011 Jun; 29(26):4422-9. PubMed ID: 21496472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection.
    Suradhat S; Intrakamhaeng M; Damrongwatanapokin S
    Vet Immunol Immunopathol; 2001 Dec; 83(3-4):177-89. PubMed ID: 11730928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus.
    Graham SP; Haines FJ; Johns HL; Sosan O; La Rocca SA; Lamp B; Rümenapf T; Everett HE; Crooke HR
    Vaccine; 2012 Apr; 30(17):2742-8. PubMed ID: 22366027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the cell-mediated immunity induced by alphavirus replicon-vectored DNA vaccines against classical swine fever in a mouse model.
    Zhao HP; Sun JF; Li N; Sun Y; Xia ZH; Wang Y; Cheng D; Qi QF; Jin ML; Qiu HJ
    Vet Immunol Immunopathol; 2009 May; 129(1-2):57-65. PubMed ID: 19150136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application.
    Frey CF; Bauhofer O; Ruggli N; Summerfield A; Hofmann MA; Tratschin JD
    Vet Res; 2006; 37(5):655-70. PubMed ID: 16777037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immunity against classical swine fever in pigs induced by prime-boost immunization using an alphavirus replicon-vectored DNA vaccine and a recombinant adenovirus.
    Sun Y; Li N; Li HY; Li M; Qiu HJ
    Vet Immunol Immunopathol; 2010 Sep; 137(1-2):20-7. PubMed ID: 20435352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors critical for successful vaccination against classical swine fever in endemic areas.
    Suradhat S; Damrongwatanapokin S; Thanawongnuwech R
    Vet Microbiol; 2007 Jan; 119(1):1-9. PubMed ID: 17097243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization of pigs against classical swine fever. Course of the disease and virus transmission after simultaneous vaccination and infection.
    Kaden V; Schurig U; Steyer H
    Acta Virol; 2001 Feb; 45(1):23-9. PubMed ID: 11394574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge.
    Sánchez O; Barrera M; Rodríguez MP; Frías MT; Figueroa NE; Naranjo P; Montesino R; Farnos O; Castell S; Venereo A; Ganges L; Borroto C; Toledo JR
    Vaccine; 2008 Feb; 26(7):988-97. PubMed ID: 18192093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
    Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
    Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
    Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
    Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
    Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
    Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.